Equities

Taiyen Biotech Co Ltd

1737:TAI

Taiyen Biotech Co Ltd

Actions
Consumer Staples Food Producers
  • Price (TWD)35.45
  • Today's Change-0.10 / -0.28%
  • Shares traded367.98k
  • 1 Year change+6.78%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,8401,8872,084
Total Receivables, Net663650758
Total Inventory395407395
Prepaid expenses------
Other current assets, total129149158
Total current assets3,0263,0943,395
Property, plant & equipment, net3,9073,7133,564
Goodwill, net------
Intangibles, net6.415.348.53
Long term investments1,2681,2941,387
Note receivable - long term------
Other long term assets303426
Total assets8,3208,2128,468
LIABILITIES
Accounts payable385399485
Accrued expenses------
Notes payable/short-term debt10020288
Current portion long-term debt/capital leases231815
Other current liabilities, total594489518
Total current liabilities1,1019261,305
Total long term debt989889
Total debt220135392
Deferred income tax343434
Minority interest58141152
Other liabilities, total538492525
Total liabilities1,8291,6902,106
SHAREHOLDERS EQUITY
Common stock2,0002,0002,000
Additional paid-in capital2,5022,5022,502
Retained earnings (accumulated deficit)1,9932,0221,862
Treasury stock - common------
Unrealized gain (loss)--01.08
Other equity, total(3.38)(2.99)(3.24)
Total equity6,4916,5216,361
Total liabilities & shareholders' equity8,3208,2128,468
Total common shares outstanding200200200
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.